mass spectrometric immunoassay
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
The firm is preparing to launch a test to identify patients with few or no cognitive symptoms who will decline to Alzheimer's disease up to six years before diagnosis.
Stella Dx, University of Kansas Medical Center Collaborate on Barrett's Esophagus Panel
The partners will assess Stella's assay by quantifying proto-oncogenes in Barrett's esophagus tissue that have progressed to cancer, and those that have not.
The researchers at the Royal College of Surgeons Ireland recently received €1.3 million from Wellcome Trust to support the development of the blood-based test.
Osteoporosis Dx Firm Osteolabs Closes $1.9M Financing Round to Support Geographic, Lab Expansion
The German startup said its CE-marked, clinically validated OsteoTest detects osteoporosis and can be used to monitor therapy.